North Carolina in New York – Mountain Home Magazine
Mountain Home Magazine |
North Carolina in New York
Mountain Home Magazine In white structures rising up from the white snow, leafy greens are growing—or, if not growing exactly, waiting, in suspended animation for longer days and warmer temperatures. Just open the door, if you can get it past lumpy frozen mud and rocks, and … |
WIRED |
CRISPR technology ownership decided – The Aquinas
The Aquinas The CRISPR patent case that was being investigated since 2013 was finally decided on Wednesday, Feb. 15, 2017. The U.S. Patent and Trademark Office … Should Anyone Own the Most Powerful Gene Editing Technology Ever Invented?Gizmodo The Long-Shot Bid to Put Crispr in the Hands of the PeopleWIRED 3Q: US patent office’s ruling on CRISPRMIT News IAM (registration) (blog) –GenomeWeb –Forbes all 18 news articles » |
OncLive |
Dr. Drake on Promise of Immunotherapy Combinations in Genitourinary Cancers
OncLive Charles G. Drake, MD, PhD, director of Genitourinary Oncology, NewYork-Presbyterian/Columbia University Medical Center and co-director of Columbia’s Cancer Immunotherapy Programs, discusses the potential of combinations between immunotherapy … |
OncLive |
Dr. Drake on Promise of Immunotherapy Combinations in Genitourinary Cancers
OncLive Charles G. Drake, MD, PhD, director of Genitourinary Oncology, NewYork-Presbyterian/Columbia University Medical Center and co-director of Columbia’s Cancer Immunotherapy Programs, discusses the potential of combinations between immunotherapy … |
W Magazine |
Thanks to Stem Cell Therapy, Thinning Hair May Be a Thing of the Past
W Magazine Call me a creature of habit, or just plain boring, but I’ve been wearing my hair long, blonde, straight, and side-parted for more than 15 years. The only thing that’s really changed is how much of it I have left. Whether the result of bleach, blowouts … |
Immuno-Oncology News |
Phase 1 Trial of CAR T-Cell Drug for Pancreatic Cancer Doses First Patient
Immuno-Oncology News The Phase 1 trial assessing Bellicum Pharmaceuticals’ BPX-601, a CAR T-cell therapy against the prostate stem cell antigen (PSCA), in inoperable pancreatic cancer has dosed its first patient. The company says this is the first CAR T-cell therapy aimed … |
Gizmodo |
Should Anyone Really Control Who Gets to Use CRISPR?
Gizmodo Last week, the US Patent and Trademarks office handed down a decision in one of the most high-profile patent cases of the century. In a one sentence ruling, an appeals board granted the rights to the powerful gene editing technology CRISPR-Cas9 to the … The Long-Shot Bid to Put Crispr in the Hands of the People | WIREDWIRED 3Q: US patent office’s ruling on CRISPR | MIT NewsMIT News PTAB issues key decision over revolutionary CRISPR technology, but this tale is not over yetIAM (registration) (blog) GenomeWeb –Forbes –JD Supra (press release) all 14 news articles » |